Nature Reviews Rheumatology, Published online: 07 January 2026; doi:10.1038/s41584-025-01350-6 A large European cohort clarifies COPA syndrome as a multi-organ interferonopathy […]
Nature Reviews Rheumatology, Published online: 05 January 2026; doi:10.1038/s41584-025-01347-1 Intravenous immunoglobulin (IVIG) is a cornerstone of autoimmune disease therapy, but
Nature Reviews Rheumatology, Published online: 19 December 2025; doi:10.1038/s41584-025-01344-4 Fibromyalgia remains a challenge for researchers and clinicians. Three studies published
Nature Reviews Rheumatology, Published online: 18 December 2025; doi:10.1038/s41584-025-01346-2 A new study reveals that the Epstein–Barr virus can reprogramme autoreactive
Nature Reviews Rheumatology, Published online: 15 December 2025; doi:10.1038/s41584-025-01342-6 New research published in 2025 sheds light on the pre-clinical period
Nature Reviews Rheumatology, Published online: 11 December 2025; doi:10.1038/s41584-025-01327-5 Monogenic disorders involving key elements of the TNF pathway now encompass
Nature Reviews Rheumatology, Published online: 10 December 2025; doi:10.1038/s41584-025-01343-5 In 2025, a new wave of ‘off-the-shelf’ B cell-depleting modalities for
Nature Reviews Rheumatology, Published online: 09 December 2025; doi:10.1038/s41584-025-01341-7 Autologous haematopoietic stem cell transplantation revolutionized the treatment of severe systemic
Nature Reviews Rheumatology, Published online: 08 December 2025; doi:10.1038/s41584-025-01333-7 In this Review, the authors summarize the potential role of emerging
Nature Reviews Rheumatology, Published online: 05 December 2025; doi:10.1038/s41584-025-01340-8 A new study uncovers how UBA1 mutations in VEXAS syndrome simultaneously
Nature Reviews Rheumatology, Published online: 03 December 2025; doi:10.1038/s41584-025-01337-3 Advances in artificial intelligence (AI) are transforming patient stratification in rheumatology.
Nature Reviews Rheumatology, Published online: 03 December 2025; doi:10.1038/s41584-025-01332-8 Emerging evidence suggests a paradigm shift in viewing osteoarthritis (OA) as
Nature Reviews Rheumatology, Published online: 02 December 2025; doi:10.1038/s41584-025-01296-9 Immune-checkpoint agonists are a promising therapeutic approach for autoimmune disease. This
Nature Reviews Rheumatology, Published online: 01 December 2025; doi:10.1038/s41584-025-01339-1 Many of the current therapies for arthritis lack a targeted approach,
Nature Reviews Rheumatology, Published online: 28 November 2025; doi:10.1038/s41584-025-01338-2 T helper 17 cells that lose IL-17 expression drive inflammation in
Nature Reviews Rheumatology, Published online: 27 November 2025; doi:10.1038/s41584-025-01329-3 In this Consensus Statement, a Group for Research and Assessment of
Nature Reviews Rheumatology, Published online: 26 November 2025; doi:10.1038/s41584-025-01335-5 A nanobody that targets IL-17A and IL-17F has shown promise in
Nature Reviews Rheumatology, Published online: 26 November 2025; doi:10.1038/s41584-025-01328-4 Cam morphology can cause intra-articular joint damage and lead to femoroacetabular
Nature Reviews Rheumatology, Published online: 24 November 2025; doi:10.1038/s41584-025-01334-6 The results of the phase II DAHLIAS trial support the development
Nature Reviews Rheumatology, Published online: 24 November 2025; doi:10.1038/s41584-025-01326-6 This Review explores the complex relationship between obesity and psoriatic disease.
Nature Reviews Rheumatology, Published online: 19 November 2025; doi:10.1038/s41584-025-01321-x Childhood-onset SLE is characterized by high disease activity, severe organ damage
Nature Reviews Rheumatology, Published online: 18 November 2025; doi:10.1038/s41584-025-01330-w Findings reveal that inhibiting cytosolic phospholipase A2 in chondrocytes could be
Nature Reviews Rheumatology, Published online: 17 November 2025; doi:10.1038/s41584-025-01331-9 Author Correction: Occupational dust and chemical exposures and the development of
Nature Reviews Rheumatology, Published online: 13 November 2025; doi:10.1038/s41584-025-01323-9 The factors and mechanisms that regulate osteoclast-induced inflammatory bone loss are
Nature Reviews Rheumatology, Published online: 07 November 2025; doi:10.1038/s41584-025-01325-7 A new population-based study suggests that sodium–glucose cotransporter-2 (SGLT2) inhibitors —
Nature Reviews Rheumatology, Published online: 07 November 2025; doi:10.1038/s41584-025-01318-6 This Review discusses latest advances in the field of cutaneous lupus,
Nature Reviews Rheumatology, Published online: 06 November 2025; doi:10.1038/s41584-025-01309-7 This Review article provides an update on the pathophysiology, diagnosis and
